Search Results - Alaa Almagthali
You must be logged in first
- Showing 1 - 5 results of 5
-
1
-
2
When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study by Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Mashael AlFaifi, Majed Nahari, Alaa Almagthali, Abrar K. Thabit, Raghad Alhajaji, Reham Alharbi, Khawla Kahtani, Abeer A. Alenazi, Aisha Alharbi, Munirah M. Alghwainm, Sara M. Alotaibi, Yazeed S. Alghamdi, Samar Alotaibi, Shaden H. Alonazi, Jumanah M. Almutairi, Ramesh Vishwakarma
Published 2023-09-01
Article -
3
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study by Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Alissa, Abdullah Alharthi, Raed Kensara, Amjaad Alfahed, Ramesh Vishwakarma, Hussain Al Haji, Naif Almohaimid, Omar Al Zumai, Fahad Alrubayan, Abdulmajid Asiri, Nasser Alkahtani, Abdulaziz Alolayan, Samiah Alsohimi, Nawal Melibari, Alaa Almagthali, Seba Aljahdali, Abeer A. Alenazi, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Omar Al Faris, Joud Alqahtani, Jalal Al Qahtani, Khalid A. Alshammari, Khalil I. Alshammari, Ohoud Aljuhani
Published 2022-10-01
Article -
4
The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study by Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Ohoud Aljuhani Pharm.D, BCCCP, Ghazwa B. Korayem Pharm.D, Ali F. Altebainawi Pharm.D, Ramesh Vishwakarma PhD, Mashael AlFaifi Pharm.D, Samiah Alsohimi Pharm.D, Aljoharah Alrayes Pharm.D, Sara Albishi Pharm.D, Reem Alqahtani Pharm.D, Mai Alalawi Pharm.D, Ibrahim Al Sulaihim MSc, Thamer A. Alanazi BSc, Rahaf A. Alqahtani Pharm.D, Alaa Almagthali Pharm.D, Shahamah Jomah BSc, Areej Alshlowi BSc, Tahani R. Alshammari BSc, Shahad S. Alzahrani Pharm.D, Marwa I. Abdulqader Pharm.D
Published 2023-12-01
Article -
5
Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study by Khalid Al Sulaiman MBA, BCCCP, BCNSP, FCCM, Ohoud Aljuhani PharmD, Ghazwa B. Korayem PharmD, Lina I. Alnajjar PharmD, Ali F. Altebainawi PharmD, Mashael AlFaifi PharmD, Ramesh Vishwakarma PhD, Abeer A. Alenazi PharmD, Mai Alalawi PharmD, Abdulrahman Alissa PharmD, Yazed S. Alsowaida BSc, PharmD, Samiah Alsohimi PharmD, Alaa Almagthali PharmD, Saeed M. Alay PharmD, Noora Altaher PharmD, Mohammed G. Alamri PharmD, Dalal Alangari PharmD, Amer Alzahrani MD, Habeeb Ibrahim Abdul Razack MPharm, MSc CRRA, Jwael Alhamoud BSc, Abdulrahman Alshaya PharmD, Jawaher Gramish PharmD, Kholoud Al Aamer MSc, Alawi S. Alsaeedi MD, Ghassan Alghamdi MD
Published 2023-06-01
Article